UBS Group’s MiniMed Group Inc MMED Stock Holding History

UBS Group’s Portfolio MMED Stock Details MMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.18M	Buy	413,416 +102,067	+33%	+$1.35M	﹤0.01%	3941
2026 Q1	$4.65M	Buy	+311,349	New	+$5.13M	﹤0.01%	4152

Other funds holding MMED

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group's MMED Position: Q2 2026 in Review

UBS Group increased its MiniMed Group Inc (MMED) stake by 33% in Q2 2026, buying an estimated $1.35M and bringing the position to 413,416 shares worth $6.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3941.

UBS Group first reported a position in MMED in Q1 2026 and has held it in 2 quarters since. 98 funds tracked by Wall St. Rank hold MMED as of Q2 2026.

UBS Group held 413,416 shares of MiniMed Group Inc worth $6.18M as of Q2 2026.
UBS Group bought 102,067 MiniMed Group Inc shares in Q2 2026, an estimated $1.35M.
MiniMed Group Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3941 holding.
UBS Group first reported a position in MiniMed Group Inc in Q1 2026 and has held it in 2 quarters since.
98 funds tracked by Wall St. Rank held MiniMed Group Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.